4CMenB tied to modest gonorrhea protection in real-world study - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

4CMenB tied to modest gonorrhea protection in real-world study

The 38.4% reduction in gonorrhea risk “could translate into preventing a substantial number of infections and complications.”

  • By

  • Julia Cipriano, MS, CMPP

  • September 9, 2026

  • 4 min

Share

Original Source(s)

4CMenB tied to modest gonorrhea protection in real-world study

  • by Julia Cipriano, MS, CMPP

  • September 9, 2026

Related Content

Update on Selected Adverse Events of Concern Following Immunization With Acellular Pertussis Vaccines, a Narrative Review

Meningococcal B vaccination for gonorrhoea prevention in men who have sex with men – time to revisit the recommendation?

Response to: Methodological issues of paper about the 2025 measles outbreak in Mexico